An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy

Fangjun Cao; Hui Feng; Tie-Zhi Jin; Weiping Yang; Bin Yang

doi:10.1021/acsami.6c03483

April 27, 2026ACS Applied Materials & Interfaces

An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to investigate the effects of a novel nanozyme intervention on gut microbiota and its implications for inflammatory bowel disease treatment.
Used a nanozyme intervention in mice with colitis
Monitored changes in gut microbiota composition
Evaluated the impact on inflammatory diseases
The nanozyme intervention partially modulated gut microbiota
Promoted advantageous bacterial communities in colitis mice
Suggests potential for effective oral formulations for therapy

Implication

Nanozyme intervention alters gut microbiota in colitis mice, suggesting potential for inflammatory disease therapy.

Abstract

(-200) nanozyme intervention partially modulated the composition of gut microbiota in mice with colitis, specifically promoting the augmentation of advantageous bacterial communities. This study offers novel perspectives regarding the advancement of highly effective oral formulations for the treatment of inflammatory diseases.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cao et al. (2026) studied this question.

synapsesocial.com/papers/69f154f9879cb923c49455cc https://doi.org/10.1021/acsami.6c03483

View Full Paper

Ask AI

Bookmark

Share

An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading